Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease (original) (raw)

An Introduction to Genetics and Application to Crohnʼs Disease

Ginger Salvadalena

Journal of Wound, Ostomy and Continence Nursing, 2007

View PDFchevron_right

Bugs, genes, fatty acids, and serotonin: Unraveling inflammatory bowel disease?

Jonathan Kaunitz

F1000Research, 2015

View PDFchevron_right

Behaviour of Crohn's disease according to the Vienna classification

David Sachar

Gut, 2002

View PDFchevron_right

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

N. Mortensen

Gut, 2006

View PDFchevron_right

Death-associated protein kinase: A molecule with functional antagonistic duality and a potential role in inflammatory bowel disease (Review)

Sara Steinmann

International Journal of Oncology, 2015

View PDFchevron_right

Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations

J.enrique Domínguez-muñoz

European journal of …, 2007

View PDFchevron_right

Inflammatory bowel disease in Asia

Rupert Leong

Journal of Gastroenterology and Hepatology, 2010

View PDFchevron_right

Prevention of Post-operative Recurrence in Crohn's Disease

Kim Jong

Intestinal Research, 2008

View PDFchevron_right

Lack of association between TYK2 and STAT3 genes and Crohn’s disease in the Malaysian population

Ida Hilmi

Genetics and Molecular Research, 2013

View PDFchevron_right

Fibrotic Strictures and Anti-TNF-α Therapy in Crohn’s Disease

Giovanni Terrosu

Digestion, 2007

View PDFchevron_right

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

David Okou

Nature Genetics

View PDFchevron_right

Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future

Saurabh dawra

Future pharmacology, 2024

View PDFchevron_right

Inflammatory Bowel Disease: the Pathologists Approach to the Clinical Problem

Emil Salmo

Inflammatory Bowel Disease and Familial Adenomatous Polyposis

View PDFchevron_right

NADPH Oxidases and Inflammatory Bowel Disease

Giang Lam

Current Medicinal Chemistry, 2015

View PDFchevron_right

Combination of genetic and quantitative serological immune markers are associated with complicated Crohnʼs disease behavior

Emil Chuang

Inflammatory Bowel Diseases, 2011

View PDFchevron_right

Anti-inflammatory effect of acute stress on experimental colitis is mediated by cholecystokinin-B receptors

Mehmet Gülpınar

Life Sciences, 2004

View PDFchevron_right

Colorectal Cancer and Inflammatory Bowel Disease

Vlad Padureanu

Colorectal Cancer - From Pathogenesis to Treatment, 2016

View PDFchevron_right

What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Gökhan Kabaçam

The Turkish Journal of Gastroenterology, 2010

View PDFchevron_right

Gut dysbiosis and paediatric Crohn's disease

Rita Cozzali

Journal of Infection, 2018

View PDFchevron_right

When to use biological agents in inflammatory bowel disease

Rupert Leong

Journal of Gastroenterology and Hepatology, 2012

View PDFchevron_right

Role of the JNK signal transduction pathway in inflammatory bowel disease

Jack Bragg

World Journal of Gastroenterology, 2008

View PDFchevron_right

The Epidemiology and Phenotype of Crohn’s Disease in the Chinese Population

Rupert Leong

Inflammatory Bowel Diseases, 2004

View PDFchevron_right

G protein-coupled estrogen receptor mediates anti-inflammatory action in Crohn’s disease

Wanda Krajewska

Scientific Reports, 2019

View PDFchevron_right

Continuing low incidence of Crohn’s disease in Northwest Greece

Ioannis Dimoliatis

Digestive and Liver Disease, 2003

View PDFchevron_right

A review article of inflammatory bowel disease treatment and pharmacogenomics

Nashwa Eltantawy

Beni-Suef University Journal of Basic and Applied Sciences, 2023

View PDFchevron_right